Sep 182017
 

SPARC Europe, Link (CC-BY)

SPARC Europe is leading and collaborating with an international coalition in an effort to halt the adoption of harmful provisions found in the current draft of the Directive on Copyright in the Digital Single Market, and certain amendments, which could threaten Open Access and Open Science.

The coalition has written an open letter directed at the EU’s Legal Affairs Committee, which was delivered 6th September. In the letter, we urge for the removal of proposals that would restrict access to research and place administrative and legal burdens on institutional repositories. We also request improvements on proposals related to text and data mining, copyright in an education setting, and preservation and access to works for non-commercial endeavors.   Continue reading »

Share
Feb 152016
 

eu-flagEuropean Commission Vice President Andrus Ansip has responded to Members of the European Parliament who expressed concern with the Commission’s consideration of ancillary copyright for press publishers as part of its upcoming copyright harmonization proposal. The so-called “Google tax”would allow press publishers to charge fees to search engines that include snippets of news stories in their search results. Vice President Ansip indicated that the Commission is undecided on whether to include the provision: Continue reading »

Share

Solutions to Improve Access to Medicines and Biomedical Innovation Through EU Trade and R&D Policy

 Posted by on November 24, 2014  Comments Off on Solutions to Improve Access to Medicines and Biomedical Innovation Through EU Trade and R&D Policy
Nov 242014
 

msf big square cropped[Médecins Sans Frontières Access Campaign] The European Union’s (EU) free trade and research and development (R&D) policies promote excessive intellectual property (IP) protection. This approach jeopardises access to affordable, needed medicines and impedes needs-driven biomedical innovation. Médecins Sans Frontières Access Campaign and our partners at HAI Europe and Oxfam are offering policy-makers seven straight-forward solutions that could transform harmful trade and R&D policy. By taking these solutions on board, the EU could enhance medicines access and pharmaceutical innovation in the EU and around the world.

Download the full document (PDF)

Share

European Copyright Society: Limitations and Exceptions as Key Elements of the Legal Framework for Copyright in the EU

 Posted by on November 3, 2014  Comments Off on European Copyright Society: Limitations and Exceptions as Key Elements of the Legal Framework for Copyright in the EU
Nov 032014
 

EU flagOpinion on the Judgment of the CJEU in Case C-201/13 Deckmyn

Abstract: In this opinion, the European Copyright Society (ECS) puts on record its views on the issues raised by the Judgment of the Court of Justice of the European Union (CJEU) in Case C-201/13, Deckmyn, which departs from the doctrine of strict interpretation of exceptions and limitations in cases in which fundamental rights such as freedom of expression are involved. Continue reading »

Share

Fifth European Parliament Committee Rejects ACTA

 Posted by on June 21, 2012  Comments Off on Fifth European Parliament Committee Rejects ACTA
Jun 212012
 

Today the EP Committee on International Trade (INTA) voted to 19-12 to recommend that the full Parliament reject ACTA.  It formally adopted David Martin’s draft report on the agreement, which formally advises the Parliament to decline to give its consent to ACTA, noting that “intended benefits of this international agreement are far outweighed by the potential threats to civil liberties. Given the vagueness of certain aspects of the text and the uncertainty intended benefits of this international agreement are far outweighed by the potential threats to civil liberties.” Continue reading »

Share

European Parliament to Seek Further ECJ Guidance on ACTA; Receives Petition; Holds Public Hearing

 Posted by on March 2, 2012  Comments Off on European Parliament to Seek Further ECJ Guidance on ACTA; Receives Petition; Holds Public Hearing
Mar 022012
 

February 28:  MEP and ACTA Rapporteur David Martin indicated he wants the European Parliament to refer ACTA to the European Court of Justice to ensure that the agreement does not conflict with other treaty obligations and EU Common Law.  [see European Parliament press release]  He believes that “Parliament should prepare its own questions, rather than simply associating itself with the European Commission’s parallel referral of ACTA to the court.” Continue reading »

Share